Immunosuppression: Preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistiocytosis (FHL)
- 1 January 1994
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 22 (5) , 325-328
- https://doi.org/10.1002/mpo.2950220505
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1991
- Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursThe Lancet, 1991
- Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemiaCancer, 1991
- Myeloid neoplasia in children treated for solid tumoursThe Lancet, 1990
- Familial erythrophagocytic lymphohistiocytosis: Late relapse despite continuous high‐dose VP‐16 chemotherapyMedical and Pediatric Oncology, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Use of VP-16–213 in the treatment of familial erythrophagocytic lymphohistiocytosisCancer, 1986
- Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16–213Cancer, 1980
- Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosisCancer, 1979
- Familial Haemophagocytic ReticulosisArchives of Disease in Childhood, 1952